Firefly Neuroscience, INC 8-K filings

NASDAQ
FireFly Neuroscience announces the appointment of David DeCaprio to its Board of Directors, a key step towards its anticipated NASDAQ listing following the merger with WaveDancer, Inc.
NASDAQ
WaveDancer and Firefly Neurosciences have received stockholder approval to proceed with their merger, a key step towards creating an AI-driven brain health company.
NASDAQ
WaveDancer stockholders have approved a merger with Firefly Neuroscience, along with a reverse stock split, a new charter, an incentive plan, and the sale of Tellenger, Inc.
NASDAQ
WaveDancer's Chief Financial Officer, Timothy G. Hannon, has resigned effective March 22, 2024, to pursue another career opportunity.
NASDAQ
A white paper reveals Firefly Neuroscience's BNA platform significantly improves treatment outcomes for patients with mental illnesses, based on a study of 2,253 patients.
NASDAQ
Firefly Neuroscience and WaveDancer are moving forward with their proposed merger, with a shareholder vote scheduled for March 14, 2024, to approve the transaction.
NASDAQ
WaveDancer has filed a registration statement with the SEC for its proposed merger with Firefly Neuroscience, an AI-enabled medical technology company.
NASDAQ
WaveDancer and Firefly Neuroscience have amended their merger agreement to clarify the timing of the merger, the treatment of warrants, and remove HSR Act closing obligations.